Brian Cummings, an associate professor in the College of Pharmacy, received $23,934 from Chevron Chemical Co. to test the toxicity of various metal-based anti-cancer drugs on kidney cells.
Brian Cummings, an associate professor in the College of Pharmacy, received $23,934 from Chevron Chemical Co. to test the toxicity of various metal-based anti-cancer drugs on kidney cells.
